Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 19, 2016 07:00 ET | Source: Karyopharm Therapeutics

Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial in Multiple Myeloma

NEWTON, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today the initiation of a Phase 1/2 study of oral...
January 14, 2016 07:00 ET | Source: Karyopharm Therapeutics

Karyopharm Initiates Clinical Trial of Oral Selinexor in Advanced Liposarcoma

NEWTON, Mass., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today the initiation of Selinexor in Advanced...
January 04, 2016 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm to Present at the 34th Annual J.P. Morgan Healthcare Conference

NEWTON, Mass., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael G. Kauffmann, MD, PhD, Chief...
December 07, 2015 10:00 ET | Source: Karyopharm Therapeutics

Karyopharm Therapeutics Presents Positive Clinical Data on the Activity of Selinexor in Combination with Other Anticancer Agents across Multiple Hematologic Malignancies at the 2015 American Society of Hematology (ASH) Annual Meeting

- Selinexor Demonstrates Promising Activity and Tolerability in Combination with Other Active Agents - - Encouraging Efficacy and Tolerability Observed in Patients with Heavily Pretreated...
November 30, 2015 16:01 ET | Source: Karyopharm Therapeutics

Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Hematologic Malignancies

NEWTON, Mass., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the presentation of clinical data for its lead...
November 09, 2015 07:30 ET | Source: Karyopharm Therapeutics

Karyopharm Reports Third Quarter 2015 Financial Results and Highlights Recent Progress

– Robust Recruitment and New Study Initiations Continue – – Additional Encouraging Data on Selinexor in Combination with Other Active Agents to be Presented at ASH...
November 05, 2015 09:05 ET | Source: Karyopharm Therapeutics

Karyopharm to Present Data on Oncology Pipeline at American Society of Hematology 2015 Annual Meeting

NEWTON, Mass., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that 17 abstracts, including 5 oral presentations...
November 02, 2015 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm to Report Third Quarter 2015 Financial Results on November 9, 2015

NEWTON, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it will report third quarter 2015 financial...
October 19, 2015 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm Initiates STOMP Clinical Trial of Oral Selinexor in Multiple Myeloma

NEWTON, Mass., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today the initiation of the Selinexor and Backbone...
September 03, 2015 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm Advancing Neuroprotective SINE(TM) Compounds in Amyotrophic Lateral Sclerosis (ALS)

– Preclinical efficacy of SINE™ compounds validated in journal Nature publication – – Presentations of ALS abstracts at upcoming AAN and SfN meetings – –...